SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge📊Experiments🤖Agents🚦Status📑Docs
Info
ℹVision⭐Showcase📽Demo
📖

CRISPR Gene Editing for Parkinson's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-crispr-gene-editing-pa
Related Entities
therapeutics-crispr-gene-editing-parkinsons
Metadata
slugtherapeutics-crispr-gene-editing-parkinsons
entity_typetherapeutic
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (274)
mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction100%
mentions🔬Can speech, gait, retinal imaging, sleep, and smartphone dat100%
mentions🔬SPMs (resolvins, protectins, maresins) from omega-3s may pro100%
mentions🔬Analysis question not specified100%
mentions🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon100%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP80%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di75%
mentions🔬How can CRISPR systems achieve persistent therapeutic effect75%
related🧫CRISPR Gene Correction Approaches for CBS/PSP72%
mentions🧫CRISPR/Cas9-mediated humanization of mouse IgG1 Fc domain in70%
mentions🧫Generation of Aβ-specific Tregs using CRISPR-Cas970%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫Proposed experiment from debate on Microglia activate astroc70%
mentions🧫s:** - Test whether HCN1 knockout specifically in EC layer I70%
mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%
mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%
mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%
mentions🧫s:** - Compare uptake with/without magnetic particles using 70%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%
mentions🧫Proposed experiment from debate on Perivascular spaces and g70%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr70%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%
mentions🧫s:** - Dose-response studies showing therapeutic window with70%
mentions🧫Proposed experiment from debate on Senolytics targeting p16/70%
mentions🧫Proposed experiment from debate on Microglia activate astroc70%
mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera70%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%
mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%
mentions🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka70%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%
mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa70%
mentions🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 70%
mentions🧫Epigenetic Dysregulation in Huntington's Disease — Ther70%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise70%
mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki70%
mentions🧫Experiment Validation: In vitro ThT Assay70%
mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement70%
related🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon70%
related🧫CRISPR Gene Correction Approaches for CBS/PSP70%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di67%
related🔬How can CRISPR systems achieve persistent therapeutic effect67%
mentions🧪Smartphone-Detected Motor Variability Correction66%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation65%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade64%
related🧫CRISPR/Cas9-mediated humanization of mouse IgG1 Fc domain in63%
related🧫Generation of Aβ-specific Tregs using CRISPR-Cas963%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫Proposed experiment from debate on Microglia activate astroc63%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I63%
related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%
related🧫s:** - Temporal analysis showing mitochondrial defects prece63%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%
related🧫s:** - Compare uptake with/without magnetic particles using 63%
related🧫Proposed experiment from debate on Mitochondrial transfer be63%
related🧫Proposed experiment from debate on Perivascular spaces and g63%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr63%
related🧫Proposed experiment from debate on Mitochondrial transfer be63%
related🧫s:** - Dose-response studies showing therapeutic window with63%
related🧫Proposed experiment from debate on Senolytics targeting p16/63%
related🧫Proposed experiment from debate on Microglia activate astroc63%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera63%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau63%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%
related🧫Blood-Based Biomarker Panel for Early AD Detection63%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka63%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT63%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa63%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 63%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther63%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise63%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki63%
related🧫Experiment Validation: In vitro ThT Assay63%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an63%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement63%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Cytochrome Therapeutics60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
related🧪Smartphone-Detected Motor Variability Correction59%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation58%
related🧪Enteric Nervous System Prion-Like Propagation Blockade57%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne50%
mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice50%
mentions🧫TLR expression in α-synuclein overexpressing mice50%
mentions🧫Dexamethasone treatment study in α-synuclein mice50%
mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%
mentions🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪CYP46A1 Overexpression Gene Therapy50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
see_also📖Integrated Stress Response in Neurodegeneration45%
mentions🧫s:** - ALOX15 overexpression in healthy astrocytes should be44%
mentions🧫Multi-omics analysis of myricanol effects on gene expression44%
mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise44%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub35%
related🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci35%
related🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR35%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy35%

💬 Discussion

SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub